BMO cuts ServiceNow stock price target on organic growth outlook By Investing.com

BMO Capital cut its price target on ServiceNow to $115 from $120 while keeping an Outperform rating, citing disappointing organic current remaining performance obligations guidance despite results that were mostly in line with expectations. The stock trades at $103, down 45% over the past six months, and BMO still sees ServiceNow as well-positioned in AI with an attractive valuation. The broader analyst backdrop remains cautious, with several firms also trimming targets after first-quarter fiscal 2026 results.

Analysis

The first-order read is slower organic momentum, but the more important second-order issue is valuation reset risk in a stock that was still being priced for durable 20%+ compound growth. If current performance obligations decelerate while AI positioning remains more narrative than monetizable, the multiple can compress further before fundamentals stabilize. That creates a gap between “good business” and “good stock” that may persist for several quarters.

The near-term catalyst path is asymmetric to the downside because guidance revisions tend to matter more than headline beats for high-duration software names. Delayed enterprise deals, especially in longer-cycle geographies, can roll through backlog conversion with a lag of one to two quarters, so this is not just a one-print issue. If management can re-accelerate organic cRPO on the next two calls, the stock can retrace sharply; if not, the street will likely continue to ratchet down targets and de-rate the multiple.

Competitively, this is a relative rather than absolute opportunity. Large workflow software peers with clearer monetization of AI and less M&A noise should outperform on a “quality of growth” basis, while NOW may underperform until investors see evidence that AI is adding incremental deal velocity rather than just messaging support. The contrarian view is that the drawdown may already be discounting most of the bad news; however, with estimates still vulnerable, a cheap-looking valuation can remain a trap if organic growth keeps stepping down.

Key Decisions for Investors

• Short NOW on strength over the next 1-2 weeks, using a tight risk cap above recent rebound highs; base case is continued multiple compression if the next management commentary does not re-accelerate organic cRPO.
• Pair trade: long MSFT or SNOW vs short NOW for 1-3 months to isolate AI monetization quality; NOW is more exposed to scrutiny on organic growth while larger-platform names have better proof points.
• Buy NOW downside protection 2-4 months out if holding a long-book position; implied volatility should still be cheaper than the risk of another target-cut wave.
• If NOW drops another 8-12% and management signals stabilization in the next quarter, cover half the short and reassess for a tactical mean-reversion trade.
• Avoid bottom-fishing NOW until there is evidence that delayed deals are converting and organic cRPO is inflecting back above the mid-teens; without that, the stock is likely a value trap rather than a displaced leader.